May 10, 2026 - 06:52

A cruise ship carrying a confirmed outbreak of hantavirus has arrived at the port of Santa Cruz de Tenerife, prompting a coordinated health response from local authorities. The vessel, which had been sailing under heightened medical protocols, was cleared to dock after passengers and crew were evaluated by Spanish health officials.
Hantavirus is a severe, often fatal respiratory disease typically transmitted through contact with rodent droppings, urine, or saliva. While human-to-human transmission is considered extremely rare, it has been documented in isolated cases, particularly in South America. The virus causes Hantavirus Pulmonary Syndrome, which can lead to rapid lung failure.
The ship's operator confirmed that a small number of individuals onboard had developed symptoms consistent with the virus. Those affected were isolated and are receiving medical care. No further details on the number of cases or the nationality of the patients have been released. The vessel was originally scheduled to continue its itinerary, but the outbreak forced an unscheduled stop.
Local health authorities have begun contact tracing and are working with the cruise line to disinfect the ship. Passengers who are not symptomatic have been allowed to disembark but are being monitored. The incident has raised concerns about the spread of rare diseases in confined environments like cruise ships, where close quarters can amplify transmission risks. This is not the first time a cruise has faced a viral outbreak, but hantavirus remains far less common than norovirus or influenza in such settings.
November 6, 2026 - 22:39
Catherine K. Ettman Honored with Early Career Award in Population HealthCatherine K. Ettman, PhD, has been awarded the prestigious Early Career Award in Population Health by the Milbank Quarterly. The recognition took place during the 2026 Interdisciplinary Association...
November 6, 2026 - 13:26
MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicinesMRM Health, a biotech company focused on developing microbiome-based treatments for immune-mediated diseases, has partnered with Biocodex, a well-established French pharmaceutical firm with over 70...
November 5, 2026 - 23:47
Climate Adaptation Aid Pledge Falls Short for Developing NationsThe commitment to triple climate adaptation funding made during the recent UN climate summit in Brazil is not enough to meet the needs of developing nations. Despite the ambitious target, experts...
November 5, 2026 - 12:27
Impact of CVS Health Split on Connecticut PharmaciesConnecticut`s pharmacy landscape is undergoing significant changes, with the state currently listing 569 active pharmacies. This marks a decline of 128 from the peak of 697 pharmacies recorded in...